Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 5,857-5,868 of 10,592
Drug study icon
TerminatedNCT02557945

Gabapentin in Patients at Clinical Risk for Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 30 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
Drug study icon
CompletedNCT00320736

Galantamine for Cognition in People With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
North Suffolk Mental Health Association
Condition
Schizophrenia
Drug study icon
CompletedNCT00181636

Galantamine-CR and Cognitive Dysfunction in Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Bipolarity
Device study icon
TerminatedNCT01749800

Galvanic Vestibular Stimulation and Motor Training in Traumatic Brain Injury Survivors

This study exists to see whether this type of care is workable and worth testing more broadly. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

In United States
ADHDDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 70 Years
Countries
United States
Sponsor
Spaulding Rehabilitation Hospital
Condition
ADHD
Behavioral study icon
TerminatedNCT05313334

GAMBIT Task With PTSD and Healthy Control Participants

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSDBehavioralFrom 18 Years to 55 Years
Countries
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Condition
PTSD
Behavioral study icon
CompletedNCT04799717

Game-based Telehealth Therapeutic Intervention in First Onset Psychosis

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can better prevent setbacks and support longer-term stability.

Remote / online
SchizophreniaBehavioralFrom 10 Years to 18 Years
Countries
United States
Sponsor
Stanford University
Condition
Schizophrenia
Drug study icon
CompletedNCT00129441

Gamma-Amino Butyric Acid (GABA)-A Alpha2/3 Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Schizophrenia
Drug study icon
CompletedNCT01339689

Ganaxolone in PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Marinus Pharmaceuticals
Condition
PTSD
Drug study icon
TerminatedNCT01526148

Gao Bipolar Spectrum Lithium/Quetiapine Study

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

Remote / online
BipolarityDrugOver 18 Years
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center
Condition
Bipolarity
Drug study icon
TerminatedNCT02909504

Gao NARASD Lithium Study

This study exists to improve how blood tests and biological markers can help identify, measure, or follow care over time. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

In United States
BipolarityDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Keming Gao
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.